You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Baseline characteristics of study subjects

From: Multi-state models for the analysis of time-to-treatment modification among HIV patients under highly active antiretroviral therapy in Southwest Ethiopia

Characteristics   n(%)
Gender (n(%)) Male 439(34.19)
  Female 845(68.81)
WHO Stage(n(%)) SI 372(28.97)
  SII 398(30.99)
  SIII 419(32.63)
  SIV 95(7.41)
Treatment at start(n(%)) 1 526(40.96)
  2 67(5.22)
  3 185(14.41)
  4 82 (6.39)
  5 401(31.23)
  6 23(1.79)
Age (Median (IQR))   30 (26-35)
Baseline CD4 (Median (IQR))   137(78-201)
Status at the end(n(%)) Dead 52(4.05)
  Drop 197(15.34)
  Transfer 127(9.89)
  Under follow up 908(70.72)
  1. Note: 1: d4T + 3TC + NVP, 2: d4T + 3TC + EFV, 3: AZT + 3TC + NVP, 4: AZT + 3TC + EFV, 5: TDF + 3TC + EFV, and 6: TDF + 3TC + NVP